Dietrich A. Stephan - 13 Feb 2023 Form 4 Insider Report for NeuBase Therapeutics, Inc.

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Dietrich Stephan
Issuer symbol: N/A
Transactions as of: 13 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 15 Feb 2023, 18:30:41 UTC
Previous filing: 30 Sep 2022
Next filing: 17 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NBSE	Common Stock	Options Exercise	$0	+655,000	+80%	$0.000000	1,471,775	13 Feb 2023	Direct	F1
holding	NBSE	Common Stock						1,273,819	13 Feb 2023	See footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NBSE	Stock option (right to buy)	Options Exercise	$0	-655,000	-26%	$0.000000	1,864,680	13 Feb 2023	Common Stock	655,000	$0.000000	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by the reporting person as a tenant by the entirety with his spouse.
F2	These shares are held in an irrevocable trust in which the spouse of the reporting person is the investment trustee, and the spouse and the descendants of the reporting person are its beneficiaries, and another irrevocable trust in which the reporting person is the investment trustee, and the reporting person and the descendants of the reporting person's spouse are its beneficiaries.